Ticagrelor Significantly Reduces Death from Vascular Causes

Ticagrelor Significantly Reduces Death from Vascular Causes – MM1408

Over the last two decades, anti-platelet therapy has become the cornerstone in the treatment of patients with ischaemic cardiovascular disease, since such drugs effectively reduce arterial thrombotic events.

Modern Medicine – August 2014

Verified by ExactMetrics